NIH received $710m in royalties from pharma firms during the pandemic, raising public distrust in transparency.
The National Institutes of Health (NIH) received $710m in royalties from pharmaceutical firms during the pandemic, with payments related to licensed medical innovations from government scientists. This information, initially hidden, has increased public distrust in the government's transparency and motives amidst concerns about the relationship between the government and Big Pharma.
June 02, 2024
3 Articles